Navigation Links
'Reprogrammed' treatment-resistant lymphomas respond to cancer drugs
Date:8/16/2013

PHILADELPHIA A phase I clinical trial showed diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

Patients whose lymphomas recur after initial chemotherapy are treated with a combination of approaches, including high-dose chemotherapy followed by a stem cell transplant. However, some patients have tumors that do not respond to these extensive second treatments, and many of these patients die within two years of diagnosis.

"When lymphomas are formed, they shut down the cellular programs that sense that something is wrong in the cells. Once these fail-safe mechanisms that trigger cell death are shut down, it becomes difficult to kill the tumor with chemotherapy," said Leandro Cerchietti, M.D., assistant professor at the Hematology and Oncology Division of Weill Cornell Medical College in New York. "Our study showed that using low concentrations of the DNA methyltransferase inhibitors decitabine or azacitidine, these fail-safe mechanisms can slowly be awakened to induce lymphoma cell death when chemotherapy is administered."

Cerchietti and colleagues conducted a phase I trial in patients with newly diagnosed DLBCL. Eleven of the 12 patients enrolled were more than 60 years old when diagnosed, which meant that they were at high risk for tumor recurrence after initial treatment. The patients were treated with azacitidine, in escalating doses, eight days prior to initiation of six cycles of standard chemotherapy. Side effects from pretreatment with azacitidine were minimal. Two patients who were treated with the maximum dose of azacitidine had dose-limiting toxicities.

Of the 12 patients, 11 had a complete response and 10 remained in complete remission for up to 28 months.

"We showed that aggressive lymphomas can be rep
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Protein lost in tumors blocks normal cells from being reprogrammed into stem cells
2. Some patients with treatment-resistant colorectal cancers may have a new option
3. A new route for tackling treatment-resistant prostate cancer
4. High-dose Vorinostat effective at treating relapsed lymphomas
5. High Complexity Laboratory Testing Supports New Targeted Therapies for Leukemias and Lymphomas
6. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
7. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $250,000 Bard Mesh Trial Verdict
8. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
9. Human cells respond in healthy, unhealthy ways to different kinds of happiness
10. Ecommerce Solution Expert Shopping Cart Elite Adds Dynamic Tags for Populating the Auto-Responder Support Desk Messages
11. New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 The Conrad ... a total of $6.9 million, which will help ... Niger and Burkina Faso. , The programs cover three ... first will focus on fixing water points in disrepair, ... of local people to maintain water points and ensuring ...
(Date:3/4/2015)... March 04, 2015 Nike Swim Camps ... staff whose mission is to stimulate a love of ... Swim Camps provide campers the opportunity to train with ... says Paul Merrion, Vice President of US Sports Camps. ... each swimmer to build confidence and improve their technique.” ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nitrosigine®, a ... ingredient in premium sports nutrition products, is hosting the ... booth in the Terrace Ballroom at The Arnold Sports ... March 5, 2015 to March 8, 2015. , ... with FDA New Dietary Ingredient notification status; now affirmed ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, ... for Vasculitis. Vasculitis is a disease that features tenderness ... diseases is not known. Vasculitis can affect any body ... Symptoms can include fever, weight loss, tiredness, aches, pains, ... a limb. Vasculitis is treatable, but it is not ...
(Date:3/4/2015)... The week of March 2nd - ... Sleep Awareness Day being recognized on March 13th, the ... financial risks associated with sleep related illnesses, costing the ... Centers of America have turned to social media with ... will virally inspire conversation regarding the disease. , ...
Breaking Medicine News(10 mins):Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4
... Just in time for National Folic Acid Awareness Week ... Rice Federation has teamed up with the National Council ... about the importance of folic acid for good health, ... their intake, such as consuming enriched rice.Research shows that ...
... Leventhal Consulting, www.leventhalconsulting.net , a high-end consulting ... opened today in Washington, DC. Leventhal Consulting ... clients over the phone, through e-mail, and in ... Consulting consists of four elements: (a) Customized ...
... Jan. 5 The National Federation of the Blind ... in the United States, in partnership with the Sendero ... (CES), held January 6-11, 2009, in Las Vegas. ... will feature a booth sponsored by the National Federation ...
... OAKLAND, Calif., Jan. 5 Kaiser Permanente announced today,that it ... years,to sponsor the IHI Open School for Health Professions, an ... Funding for the new IHI Open School demonstrates Kaiser ... health care. , "I am proud ...
... 5 Clarus Ventures, LLC ("Clarus Ventures"), a leading ... of Edward Scolnick, M.D., as a Venture Partner and ... Firm,s Cambridge, Mass. office."Both Drs. Scolnick and Kuruvilla have ... and technology," said Nick Galakatos, Ph.D., a Managing Director ...
... - This is a reissue of a previously killed ... to use the contents of this,release. , ... ) is encouraging all parents who decide,to give up smoking ... they will save towards their children,s futures. , ...
Cached Medicine News:Health News:USA Rice Federation Partners with National Council on Folic Acid to Promote National Folic Acid Awareness Week 2Health News:USA Rice Federation Partners with National Council on Folic Acid to Promote National Folic Acid Awareness Week 3Health News:Leventhal Consulting Opens for Business 2Health News:National Federation of the Blind to Exhibit at Consumer Electronics Show 2Health News:Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvement's New Open School for Health Professions 2Health News:Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvement's New Open School for Health Professions 3Health News:Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla 2Health News:Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla 3Health News:New Year Quitters Urged to Invest in Their Family's Futures 2
(Date:3/4/2015)... 2015 Following the reintroduction of the ... (LAC) released a report today urging policymakers to ... heroin epidemic through more effective use of medication-assisted ... Case for Expanding Access to Medication-Assisted Treatment to ... health, justice, and economic advantages of medication-assisted treatment ...
(Date:3/4/2015)... FRAMINGHAM, Mass. , March 4, 2015   ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that CEO Doug Godshall ... Healthcare Conference at 8:00 a.m. Eastern Time on Tuesday, ... 10-12 at the Loews Miami Beach Hotel in ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Negative Pressure Wound Therapy Market ... Industry Analysis, Size, Share, Growth, Trends and Forecast ... , The global negative pressure ... and by geography. By product types the NPWT ...
Breaking Medicine Technology:Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2
... Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBx™, ... experience demonstrates the isotope-free cancer treatment platform is a patient and ... applications at the 11th Annual Meeting of the American Society of ... , , ...
... , April 28 Amicus Therapeutics (Nasdaq: FOLD ) will ... on Thursday, May 6, 2010 . The results announcement will be followed ... EDT . , , , ... investors may access the conference call at 5 p.m. EDT by ...
Cached Medicine Technology:12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 212 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 312 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 4Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010 2
... FIO 2 500ML 0.45% Sodium Chloride ... performance and ease of use. You can obtain ... to 100% FIO 2 . We offer a ... USP; 0.45% sodium chloride inhalation, USP; and 0.9% ...
... Prefilled 28%-100% FIO 2 500ML 0.9% Sodium ... prefilled nebulizers provide unmatched performance and ease of ... aerosols adjustable from 28% to 100% FIO 2 ... sterile water for inhalation, USP; 0.45% sodium chloride ...
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
MISTY OX® Gas Injection Nebulizer (GIN)...
Medicine Products: